Search results for query: *

I got maybe two years in me. Maybe. For me, it’s either some improvement via Ebselen or game over.

Is there any progress on research?

The more I look into this drug, the more I believe Sound Pharmaceuticals really know this drug will be effective for many non-Ménière’s patients as well. This is an excerpt from their Phase 2b data release: “These improvements in auditory function further support the use of SPI-1005 to treat...

They are in phase 3 for Ménière’s, but it could very well treat cochlear inflammation for some of us here. The research article was just highlighting the relationship between Aminoglycosides and hearing damage.

If need be, I would prepare a 20-page research paper for my physician on the potential benefits of this drug. At this point, I will not take no for an answer.

Let’s say it gets approved for treating respiratory issues related to COVID-19. Do you think we would be able to easily access it off-label for cochlear inflammation? I can see a hearing loss drug being used off-label for tinnitus, but I don’t see many physicians easily prescribing a...

Insightful share. I am really looking forward to this drug becoming accessible.

Completely forgot about that. That is huge.

They got the green light from the FDA to initiate Phase 3. However, I’m not sure when it will begin or how long it will run. I wish it was available next year, but I don’t see it hitting the market until at least 2022 when you consider recruitment, trial length, analysis, FDA approval, and...

I think this drug could be very beneficial. We know its primary aim is to target Ménière’s, but I believe many of us here may have a form of cochlear inflammation. Going off data from their previous trial, tinnitus severity was reduced for a good amount of participants. I have an intense...

https://www.prnewswire.com/news-releases/sound-pharmaceuticals-files-ind-to-test-spi-1005-in-phase-2-covid-19-trials-301103291.html “Sound Pharmaceuticals (SPI) is pleased to announce the filing of an Investigational New Drug Application with the FDA to begin Phase 2 studies to prevent and...

I was thinking about this. Should there be a difference in tinnitus effectiveness if a person doesn’t have Ménière’s Disease? Tinnitus is tinnitus, right? Ménière’s Disease does damage to the inner ear causing hearing loss which influences tinnitus prevalence. I would think the effect on...

I’ve also reached out to the company regarding their stance on expanded access. This may be a helpful drug due to its safety profile and effectiveness on inflammation. 30% reduction in tinnitus loudness for the 400 mg group? This seems to be worth a shot. This is exciting.

Not sure if this drug can help non-Meniere’s sufferers also, but Sound Pharmaceuticals does have treatments in the pipeline for hearing loss and tinnitus. Per my discussion with CEO and Chief Medical Officer, Jonathan Kil: “Yes we have four active INDs in hearing loss and tinnitus indication...